Bioadaptives, Inc. SEC filings BDPT
Bioadaptives, Inc. has 176 filings in SEC EDGAR's recent list, going back to May 3, 2013. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 4, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| NT 10-Q | Form nt 10-q | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 14, 2026 | Dec 31, 2025 |
| NT 10-K | Form nt 10-k | Mar 31, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| NT 10-K | Form nt 10-k | Mar 31, 2025 | Dec 31, 2024 |
| DEF 14C | Information statement | Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2025 | Mar 13, 2025 |
| DEF 14C | Information statement | Mar 14, 2025 | Mar 14, 2025 |
| SEC STAFF ACTION | Filing | Feb 24, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 27, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 20, 2024 | May 20, 2024 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 30, 2024 | Oct 28, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 22, 2024 | May 20, 2024 |
| 10-Q | Quarterly report | May 17, 2024 | Mar 31, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Auditor change
|
May 14, 2024 | May 13, 2024 |
| 10-K | Annual report | Apr 10, 2024 | Dec 31, 2023 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 1-A | Filing | Oct 11, 2023 | — |
| 1-Z | Filing | Aug 24, 2023 | — |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Apr 6, 2023 | Apr 6, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| DEF 14C | Information statement | Mar 28, 2023 | Mar 27, 2023 |
| PRE 14C | Pre14c | Mar 9, 2023 | Mar 8, 2023 |
| QUALIF | Filing | Nov 17, 2022 | — |
| CORRESP | Letter to the SEC | Nov 15, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 1-A POS | Filing | Nov 8, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2022 | — |
| CORRESP | Letter to the SEC | Oct 28, 2022 | — |
| 1-A POS | Filing | Oct 28, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2022 | — |
| 1-A POS | Filing | Oct 7, 2022 | — |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2022 | Jun 9, 2022 |
| 253G1 | Form 253g1 | May 16, 2022 | — |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| QUALIF | Filing | May 11, 2022 | — |
| CORRESP | Letter to the SEC | May 9, 2022 | — |
| 1-A/A | Filing | May 3, 2022 | — |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| UPLOAD | Letter from the SEC | Mar 30, 2022 | — |
| 1-A/A | Filing | Mar 18, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2022 | — |
| DEF 14C | Information statement | Mar 15, 2022 | Mar 14, 2022 |
| 1-A | Filing | Mar 4, 2022 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 3, 2022 | Feb 2, 2022 |
| PRE 14C | Filing | Jan 27, 2022 | Jan 26, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 21, 2022 | Jan 20, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2021 | Dec 15, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 27, 2021 | Aug 26, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Jul 22, 2021 | Jul 22, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jun 11, 2021 | May 31, 2021 |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Mar 30, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Other events
|
Jun 16, 2020 | Jun 16, 2020 |
| 10-Q/A | Amended quarterly report | Jun 11, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Jun 10, 2020 | Mar 31, 2020 |
| 10-K/A | Amended annual report | May 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
May 11, 2020 | May 11, 2020 |
| 10-K | Annual report | May 1, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Mar 30, 2020 | Mar 30, 2020 |
| DEF 14C | Information statement | Mar 4, 2020 | Mar 2, 2020 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Feb 11, 2020 | Feb 6, 2020 |
| PRE 14C | Filing | Feb 10, 2020 | Feb 7, 2020 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 27, 2019 | Sep 11, 2019 |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| UPLOAD | Letter from the SEC | Aug 1, 2019 | — |
| 10-12G/A | Filing | Jul 23, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2019 | — |
| 10-12G/A | Filing | Jun 27, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2019 | — |
| 10-12G | Filing | May 10, 2019 | — |
| 15-15D | Filing | Mar 31, 2017 | — |
| 10-Q | Quarterly report | Nov 18, 2016 | Sep 30, 2016 |
| NT 10-Q | Filing | Nov 15, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 18, 2016 | Jun 30, 2016 |
| NT 10-Q | Form 12b-25 | Aug 16, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 23, 2016 | Mar 31, 2016 |
| NT 10-Q | Form 12b-25 | May 17, 2016 | Mar 31, 2016 |
| 10-K | Annual report | Apr 14, 2016 | Dec 31, 2015 |
| NT 10-K | Form 12b-25 | Mar 31, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Nov 23, 2015 | Sep 30, 2015 |
| NT 10-Q | Form 12b-25 | Nov 16, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 21, 2015 | Jun 30, 2015 |
| NT 10-Q | Filing | Aug 14, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 20, 2015 | Mar 31, 2015 |
| NT 10-Q | Filing | May 18, 2015 | Mar 31, 2015 |
| 8-K |
Current report
Auditor change
|
Apr 23, 2015 | Apr 23, 2015 |
| 10-K | Annual report | Apr 15, 2015 | Dec 31, 2014 |
| NT 10-K | Filing | Mar 31, 2015 | Dec 31, 2014 |
| 8-K |
Current report
Officer or director change
|
Feb 6, 2015 | Feb 6, 2015 |
| 10-Q | Quarterly report | Nov 14, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 14, 2014 | Jun 30, 2014 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 15, 2014 | Jul 13, 2014 |
| 8-K |
Current report
Other events
|
Jul 10, 2014 | Jul 8, 2014 |
| 8-K |
Current report
Material agreement, Auditor change
|
May 23, 2014 | May 20, 2014 |
| 10-Q/A | Amended quarterly report | May 20, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | May 20, 2014 | Mar 31, 2014 |
| NT 10-Q | Filing | May 15, 2014 | Mar 31, 2014 |
| 10-K | Annual report | Apr 14, 2014 | Dec 31, 2013 |
| NT 10-K | Filing | Mar 28, 2014 | Dec 31, 2013 |
| 424B3 | Prospectus | Mar 7, 2014 | — |
| 424B3 | Prospectus | Jan 14, 2014 | — |
| EFFECT | Filing | Jan 10, 2014 | — |
| S-1/A | Amended registration statement | Jan 7, 2014 | — |
| S-1 | Registration statement | Dec 2, 2013 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control
|
Oct 25, 2013 | Oct 21, 2013 |
| 10-Q | Quarterly report | Oct 21, 2013 | Sep 30, 2013 |
| 8-K |
Current report
Unregistered share sale
|
Oct 8, 2013 | Oct 1, 2013 |
| D | Filing | Oct 8, 2013 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 30, 2013 | Sep 24, 2013 |
| UPLOAD | Letter from the SEC | Aug 19, 2013 | — |
| 10-Q | Quarterly report | Aug 13, 2013 | Jun 30, 2013 |
| CORRESP | Letter to the SEC | Aug 6, 2013 | — |
| 8-K/A |
Amended current report
Change in control, Officer or director change
|
Aug 6, 2013 | Jun 21, 2013 |
| UPLOAD | Letter from the SEC | Jul 23, 2013 | — |
| 8-K |
Current report
Change in control, Officer or director change
|
Jul 5, 2013 | Jun 21, 2013 |
| UPLOAD | Letter from the SEC | Jun 11, 2013 | — |
| UPLOAD | Letter from the SEC | May 31, 2013 | — |
| CORRESP | Letter to the SEC | May 31, 2013 | — |
| 10-12G/A | Form 10 | May 31, 2013 | — |
| 10-12G | Form 10 | May 3, 2013 | — |
Showing 143 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BDPT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1575142
- Former names
- APEX 8 Inc. (until Aug 19, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.